Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
1CMMILFF -32.49%46 Days Sales Outstanding is 6.82 as of May. 2026, which is 78% below its 10-year median of 30.44. GuruFocus rates MILFF with a GF Score™ of 46/100 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 946 Drug Manufacturers companies, 1CM ranks better than 98.73% on this metric.
1CM's average Accounts Receivable for the
three
months ended in May. 2026 was $1.02 Mil. 1CM's Revenue for the
three
months ended in May. 2026 was $13.65 Mil.
Hence, 1CM's Days Sales Outstanding for the
three
months ended in May. 2026 was 6.82.
The historical rank and industry rank for 1CM's Days Sales Outstanding or its related term are showing as below:
MILFF'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 2.57 Med: 30.44 Max: 84.57
Current: 5.26
During the past 13 years, 1CM's highest Days Sales Outstanding was 84.57. The lowest was 2.57. And the median was 30.44.
MILFF's Days Sales Outstanding is ranked better than 98.73% of 946
companies
in the Drug Manufacturers industry
Industry Median: 71.885
vs MILFF: 5.26
1CM's Days Sales Outstanding
increased
from May. 2025 (3.75) to May. 2026 (6.82).
1CM (OTCPK:MILFF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
1CM Days Sales Outstanding Related Terms
1CM Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for 1CM's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, 1CM's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
1CM Days Sales Outstanding vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, 1CM's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where 1CM's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
1CM (MILFF) has a Days Sales Outstanding of 6.82 as of May. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on 1CM and its competitors. This is 78% below median its historical median of 30.44. Over the past decade, 1CM's Days Sales Outstanding has ranged from 2.57 to 84.57. According to the industry distribution chart, 1CM ranks #12 out of 946 companies in the Drug Manufacturers industry, placing it in the top 1.3%.
Is 1CM's Days Sales Outstanding too high?
1CM's current Days Sales Outstanding of 6.82 is 78% below median its 10-year median of 30.44. Over the past 10 years, this metric has ranged from a low of 2.57 to a high of 84.57. The Drug Manufacturers industry median Days Sales Outstanding is 71.89. 1CM's value of 6.82 is 90.5% below this industry median. Based on the distribution chart, 1CM ranks #12 out of 946 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, 1CM has a GF Score™ of 46/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does 1CM's Days Sales Outstanding compare to ZTS?
According to the Drug Manufacturers industry distribution chart, 1CM ranks #12 out of 946 companies for Days Sales Outstanding. This places 1CM in the top 1% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 71.89. 1CM's value of 6.82 is 90.5% below this benchmark. Historically, 1CM's own Days Sales Outstanding has ranged from 2.57 to 84.57 over the past decade. While the company's 10-year median is 30.44 vs. the industry median of 71.89, 1CM has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Drug Manufacturers company?
The median Days Sales Outstanding among Drug Manufacturers companies is 71.89, based on 946 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 1CM's current Days Sales Outstanding of 6.82 is 90.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on 1CM and its competitors. For the Drug Manufacturers industry, the median Days Sales Outstanding is 71.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 1CM's current Days Sales Outstanding is 6.82, which is 78% below median its own 10-year median of 30.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 1CM stock overvalued right now?
Based on GuruFocus' analysis, 1CM (MILFF) is currently considered Modestly Undervalued. The current Days Sales Outstanding is 6.82, which is 78% below median its 10-year median of 30.44 and 90.5% below the Drug Manufacturers industry median of 71.89. 1CM's overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For 1CM (MILFF), the current Days Sales Outstanding is 6.82 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
1CM Inc is a multi-jurisdictional cannabis company focused on its retail customers and technology to democratize cannabis markets. The Company focuses on expanding its current operations through organic growth and by way of merger and acquisition transactions. It has a single operating segment, being Cannabis.
46GF Score
Get the complete analysis for MILFF
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MILFF has been successfully added to your 
